CD4 and neoplasm: To investigate the effects of innate and adaptive immunity on the final antitumor immune responses, we depleted CD4+, CD8+ and NK cells with a monoclonal antibody at 14 days after tumor cell inoculation and surgery in the 4T1 tumor model.